NEUBASE THERAPEUTICS INC's ticker is and the CUSIP is 64132K902. A total of 1 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,000 | -46.2% | 13,400 | -4.3% | 0.00% | – |
| Q1 2022 | $26,000 | +188.9% | 14,000 | +311.8% | 0.00% | – |
| Q4 2021 | $9,000 | -78.0% | 3,400 | -60.9% | 0.00% | – |
| Q3 2021 | $41,000 | 0.0% | 8,700 | 0.0% | 0.00% | – |
| Q2 2021 | $41,000 | +1266.7% | 8,700 | +173900.0% | 0.00% | – |
| Q1 2021 | $3,000 | -82.4% | 5 | -80.0% | 0.00% | – |
| Q4 2020 | $17,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |